Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes

International Journal of Molecular Medicine

Volumn 27, Issue 4, 2011, Pages 583-589

  Wang, Xiang ^a   Li, Fengfeng ^a   Fan, Cunyi ^a   Wang, Chunyang ^a   Ruan, Hongjiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aggrecan; Chondrocytes; ERK1 2; Interleukin 1 ; Matrix metalloproteinase 3 and 13; Type II collagen

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; COLLAGENASE 3; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; STROMELYSIN;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AGGRECANS; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; ENZYMES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INTERLEUKIN-1BETA; LENTIVIRUS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 79952236611     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.611     Document Type: Article

References (39)

1. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB and Bresnihan B: Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64: 1263-1267, 2005. (Pubitemid 41206240)
2. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M and Senolt L: Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38: 151-156, 2007. (Pubitemid 47248299)
3. Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40: 1-11, 1999.
4. Pelletier JP, Fernandes JC, Brunet J et al: In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. Arthritis Rheum 48: 1582-1593, 2003.
5. LaVallie ER, Chockalingam PS, Collins-Racie LA, et al: Protein kinase Czeta is up-regulated in osteoarthritic cartilage and is required for activation of NF-kappaB by tumor necrosis factor and interleukin-1 in articular chondrocytes. J Biol Chem 281: 24124-24137, 2006. (Pubitemid 44274187)
6. Martin G, Bogdanowicz P, Domagala F, Ficheux H and Pujol JP: Rhein inhibits interleukin-1 beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappa B and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation 27: 233-246, 2003.
7. Gosset M, Berenbaum F, Salvat C, et al: Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 58: 1399-1409, 2008. (Pubitemid 351705929)
8. Zayed N, Afif H, Chabane N, et al: Inhibition of interleukin-1-beta- induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum 58: 3530-3540, 2008.
9. Liacini A, Sylvester J, Li WQ and Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21: 251-262, 2002. (Pubitemid 34497016)
10. Ahmad R, Sylvester J and Zafarullah M: MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation. Cell Signal 19: 2549-2557, 2007.
11. Takaishi H, Kimura T, Dalai S, Okada Y and D'Armiento J: Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 9: 47-54, 2008. (Pubitemid 351266969)
12. Blom AB, van Lent PL, Libregts S, et al: Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 56: 147-157, 2007. (Pubitemid 46106187)
13. Badger AM, Cook MN, Swift BA, Newman-Tarr TM, Gowen M and Lark M: Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine. J Pharmacol Exp Ther 290: 587-593, 1999. (Pubitemid 29344550)
14. Domagala F, Martin G, Bogdanowicz P, Ficheux H and Pujol JP: Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis. Biorheology 43: 577-587, 2006. (Pubitemid 44221937)
15. Ryu JH and Chun JS: Opposing roles of WNT-5A and WNT-11 in interleukin-1beta regulation of type II collagen expression in articular chondrocytes. J Biol Chem 281: 22039-22047, 2006.
16. Frazer A, Bunning RA, Thavarajah M, Seid JM and Russell RG: Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-beta and interleukin-1beta. Osteoarthritis Cartilage 2: 235-245, 1994. (Pubitemid 24360866)
17. Boileau C, Pelletier JP, Tardif G, et al: The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway. Ann Rheum Dis 64: 891-898, 2005. (Pubitemid 40733915)
18. Ho LJ, Lin LC, Hung LF, et al: Retinole acid blocks proinflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem Pharmacol 70: 200-208, 2005.
19. Kimura H, Yukitake H, Suzuki H, et al: The chondroprotective agent ITZ-1 inhibits interleukin-1beta-induced matrix metalloproteinase-13 production and suppresses nitric oxide-induced chondrocyte death. J Pharmacol Sci 110: 201-211, 2009.
20. Gabay O, Gosset M, Levy A, et al: Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado-Soybean Unsaponifiables (ASU). Osteoarthritis Cartilage 16: 373-384, 2008. (Pubitemid 351309176)
21. Djouad F, Rackwitz L, Song Y, Janjanin S and Tuan RS: ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage. Tissue Eng Part A 15: 2825-2835, 2009.
22. Thiel MJ, Schaefer CJ, Lesch ME, et al: Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms. Arthritis Rheum 56: 3347-3357, 2007. (Pubitemid 47585429)
23. Altman R, Asch E, Bloch D, et al: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-1049, 1986.
24. Afif H, Benderdour M, Mfuna-Endam L, et al: Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes. Arthritis Res Ther 9: R31, 2007.
25. Calich AL, Domiciano DS and Fuller R: Osteoarthritis: can anti-cytokine therapy play a role in treatment? Clin Rheumatol 29: 451-455, 2010.
26. Furuzawa-Carballeda J, Macip-Rodriguez PM and Cabral AR: Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin Exp Rheumatol 26: 554-560, 2008.
27. Kim J, Xu M, Xo R, et al: Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthritis Cartilage 18: 424-432, 2010.
28. Legendre F, Bogdanowicz P, Martin G, et al: Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways. Clin Exp Rheumatol 25: 546-555, 2007. (Pubitemid 47455463)
29. Vincenti MP and Brinckerhoff CE: Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res 3: 381-388, 2001. (Pubitemid 33077119)
30. Stevens AL, Wishnok JS, White FM, Grodzinsky AJ and Tannenbaum SR: Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol Cell Proteomics 8: 1475-1489, 2009.
31. Radons J, Bosserhoff AK, Grassel S, Falk W and Schubert TE: p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med 17: 661-668, 2006.
32. Saba-El-Leil MK, Vella FD, Vernay B, et al: An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4: 964-968, 2003. (Pubitemid 37407464)
33. Yao Y, Li W, Wu J et al: Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 100: 12759-12764, 2003. (Pubitemid 37339972)
34. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L and Brambilla R: ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14, 2006.
35. Fremin C, Bessard A, Ezan F, et al: Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2. Hepatology 49: 930-939, 2009.
36. Krenz M, Gulick J, Osinska HE, Colbert MC, Molkentin JD and Robbins J: Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. Proc Natl Acad Sci USA 105: 18930-18935, 2008.
37. Guo SW, Liu MG, Long YL, et al: Region- or state-related differences in expression and activation of extracellular signal-regulated kinases (ERKs) in naive and pain-experiencing rats. BMC Neurosci 8: 53, 2007.
38. Wille L, Kemp ML, Sandy P, Lewis CL and Lauffenburger DA: Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production. Mol Immunol 44: 3085-3091, 2007. (Pubitemid 46610508)
39. Lefloch R, Pouyssegur J and Lenormand P: Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels. Mol Cell Biol 28: 511-527, 2008.